A detailed history of Neos Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Neos Investment Management LLC holds 29,977 shares of VRTX stock, worth $14.1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
29,977
Previous 23,890 25.48%
Holding current value
$14.1 Million
Previous $9.99 Billion 40.7%
% of portfolio
0.58%
Previous 0.62%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $2.39 Million - $2.96 Million
6,087 Added 25.48%
29,977 $14.1 Billion
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $3.87 Million - $4.23 Million
9,490 Added 65.9%
23,890 $9.99 Billion
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $1.13 Million - $1.35 Million
3,283 Added 29.53%
14,400 $5.86 Billion
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $3.76 Million - $4.03 Million
11,117 New
11,117 $3.87 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.